About Concert Bio

Concert Bio uses data science and an extensive plant-microbe database to identify and supply beneficial microbes for hydroponic greenhouse operations. This platform optimizes the plant microbiome to enhance crop growth, quality, and resilience. Growers utilizing these novel microbe products have reported measurable improvements in yield performance.

```xml <problem> Hydroponic agriculture lacks the natural soil microbiome essential for optimal plant growth, quality, and resilience. Recreating this delicate balance of microorganisms in soilless systems is a significant challenge for greenhouse growers. </problem> <solution> Concert Bio develops microbial products tailored for hydroponic agriculture by leveraging a comprehensive microbiome database and DNA sequencing to identify beneficial microbes. Their platform unlocks a new level of understanding about the hydroponic microbiome and how to improve it. By optimizing the microbial communities in greenhouse environments, Concert Bio enhances crop growth, quality, and resilience. </solution> <features> - First-of-their-kind microbe products based on species never before tried on plants. - Products developed from years of real-world data from over 30 growers worldwide. - DNA sequencing identifies all pathogens and beneficial species in the microbiome. - Microbiome monitoring service provides access to Concert Bio's expertise through regular consultations. - All equipment needed to collect and send samples is provided for the monitoring service. </features> <target_audience> Concert Bio's primary customers are hydroponic greenhouse growers seeking to improve crop yield, quality, and resilience through optimized microbial solutions. </target_audience> ```

What does Concert Bio do?

Where is Concert Bio located?

Concert Bio is based in London, United Kingdom.

When was Concert Bio founded?

Concert Bio was founded in 2021.

How much funding has Concert Bio raised?

Concert Bio has raised $1.7M.

Who founded Concert Bio?

Concert Bio was founded by Paul Rutten.

Paul Rutten - Founder/CEO

Location

London, United Kingdom

Founded

2021

Funding

$1.7M

Employees

14 employees

Investors

Ascension Nucleus Capital Theconduitconnect

Concert Bio

London, United KingdomFounded 2021142K+ followers10/10 TractionRelative Traction Score based on online presence metrics compared to companies in the same age group.

Updated 19 months ago

Funding

$1.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

CCEF

Funding rounds are not available yet.

Founders

Product

Problem

Hydroponic agriculture lacks the natural soil microbiome essential for optimal plant growth, quality, and resilience. Recreating this delicate balance of microorganisms in soilless systems is a significant challenge for greenhouse growers.

Solution

Concert Bio develops microbial products tailored for hydroponic agriculture by leveraging a comprehensive microbiome database and DNA sequencing to identify beneficial microbes. Their platform unlocks a new level of understanding about the hydroponic microbiome and how to improve it. By optimizing the microbial communities in greenhouse environments, Concert Bio enhances crop growth, quality, and resilience.

Target Audience

Concert Bio's primary customers are hydroponic greenhouse growers seeking to improve crop yield, quality, and resilience through optimized microbial solutions.

Features

First-of-their-kind microbe products based on species never before tried on plants.
Products developed from years of real-world data from over 30 growers worldwide.
DNA sequencing identifies all pathogens and beneficial species in the microbiome.
Microbiome monitoring service provides access to Concert Bio's expertise through regular consultations.
All equipment needed to collect and send samples is provided for the monitoring service.